FR2628429B1 - Variants de l'hirudine, leurs utilisations et les procedes pour les obtenir - Google Patents

Variants de l'hirudine, leurs utilisations et les procedes pour les obtenir

Info

Publication number
FR2628429B1
FR2628429B1 FR8802925A FR8802925A FR2628429B1 FR 2628429 B1 FR2628429 B1 FR 2628429B1 FR 8802925 A FR8802925 A FR 8802925A FR 8802925 A FR8802925 A FR 8802925A FR 2628429 B1 FR2628429 B1 FR 2628429B1
Authority
FR
France
Prior art keywords
hirudine
variants
obtaining
processes
improving
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR8802925A
Other languages
English (en)
French (fr)
Other versions
FR2628429A1 (fr
Inventor
Michael Courtney
Eric Degryse
Gerard Loison
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Transgene SA
Original Assignee
Transgene SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Transgene SA filed Critical Transgene SA
Priority to FR8802925A priority Critical patent/FR2628429B1/fr
Priority to DE8989400621T priority patent/DE68904330T2/de
Priority to EP89400621A priority patent/EP0332523B1/fr
Priority to ES198989400621T priority patent/ES2036809T3/es
Priority to AT89400621T priority patent/ATE84571T1/de
Priority to CA000592974A priority patent/CA1341429C/fr
Priority to PT89923A priority patent/PT89923B/pt
Priority to JP1057693A priority patent/JP2961118B2/ja
Priority to US07/320,530 priority patent/US5087613A/en
Publication of FR2628429A1 publication Critical patent/FR2628429A1/fr
Application granted granted Critical
Publication of FR2628429B1 publication Critical patent/FR2628429B1/fr
Priority to GR930400475T priority patent/GR3007254T3/el
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/815—Protease inhibitors from leeches, e.g. hirudin, eglin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/855—Proteins from animals other than mammals or birds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Removal Of Specific Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • External Artificial Organs (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
FR8802925A 1988-03-08 1988-03-08 Variants de l'hirudine, leurs utilisations et les procedes pour les obtenir Expired - Fee Related FR2628429B1 (fr)

Priority Applications (10)

Application Number Priority Date Filing Date Title
FR8802925A FR2628429B1 (fr) 1988-03-08 1988-03-08 Variants de l'hirudine, leurs utilisations et les procedes pour les obtenir
EP89400621A EP0332523B1 (fr) 1988-03-08 1989-03-06 Variants de l'hirudine, leurs utilisations et les procédés pour les obtenir
ES198989400621T ES2036809T3 (es) 1988-03-08 1989-03-06 Variantes de la hirudina, sus utilizaciones y los procedimientos para obtenerlas.
AT89400621T ATE84571T1 (de) 1988-03-08 1989-03-06 Hirudin-varianten, deren verwendung und verfahren zu deren herstellung.
DE8989400621T DE68904330T2 (de) 1988-03-08 1989-03-06 Hirudin-varianten, deren verwendung und verfahren zu deren herstellung.
PT89923A PT89923B (pt) 1988-03-08 1989-03-07 Processo para a preparacao de variantes da hiridina
CA000592974A CA1341429C (fr) 1988-03-08 1989-03-07 Variants de l'hirudine, leurs utilisations et les procedes pour les obtenir
JP1057693A JP2961118B2 (ja) 1988-03-08 1989-03-08 ヒルジン変異体とその用途及び製造方法
US07/320,530 US5087613A (en) 1988-03-08 1989-03-08 Hirudin variants
GR930400475T GR3007254T3 (enExample) 1988-03-08 1993-03-05

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8802925A FR2628429B1 (fr) 1988-03-08 1988-03-08 Variants de l'hirudine, leurs utilisations et les procedes pour les obtenir

Publications (2)

Publication Number Publication Date
FR2628429A1 FR2628429A1 (fr) 1989-09-15
FR2628429B1 true FR2628429B1 (fr) 1990-12-28

Family

ID=9364012

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8802925A Expired - Fee Related FR2628429B1 (fr) 1988-03-08 1988-03-08 Variants de l'hirudine, leurs utilisations et les procedes pour les obtenir

Country Status (10)

Country Link
US (1) US5087613A (enExample)
EP (1) EP0332523B1 (enExample)
JP (1) JP2961118B2 (enExample)
AT (1) ATE84571T1 (enExample)
CA (1) CA1341429C (enExample)
DE (1) DE68904330T2 (enExample)
ES (1) ES2036809T3 (enExample)
FR (1) FR2628429B1 (enExample)
GR (1) GR3007254T3 (enExample)
PT (1) PT89923B (enExample)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8907110D0 (en) * 1988-05-04 1989-05-10 Ciba Geigy Ag Improvements in the production of polypeptides
US5268296A (en) * 1988-06-11 1993-12-07 Ciba-Geigy Corporation DNA vector and recombinant host cell for production of hirullin P6 and P18
DE3835815A1 (de) * 1988-10-21 1990-04-26 Hoechst Ag Neue isohirudine
FR2646437B1 (fr) * 1989-04-28 1991-08-30 Transgene Sa Nouvelles sequences d'adn, leur application en tant que sequence codant pour un peptide signal pour la secretion de proteines matures par des levures recombinantes, cassettes d'expression, levures transformees et procede de preparation de proteines correspondant
US5663141A (en) * 1989-12-01 1997-09-02 Basf Aktiengesellschaft Hirudin/polyalkylene glycol conjugates and hirudin muteins
US5780303A (en) * 1990-04-06 1998-07-14 La Jolla Cancer Research Foundation Method and composition for treating thrombosis
US6521594B1 (en) 1990-04-06 2003-02-18 La Jolla Cancer Research Foundation Method and composition for treating thrombosis
US5612311A (en) * 1990-04-06 1997-03-18 La Jolla Cancer Research Foundation Method and composition for treating thrombosis
US5672585A (en) * 1990-04-06 1997-09-30 La Jolla Cancer Research Foundation Method and composition for treating thrombosis
JP3111075B2 (ja) * 1990-07-24 2000-11-20 メレルダウファーマスーティカルズ インコーポレイテッド 抗凝固ペプチド
US5574012A (en) * 1990-07-24 1996-11-12 Merrell Pharmaceuticals Inc. Analogs of hirudin having anti-platelet activity
AU640502B2 (en) * 1990-07-24 1993-08-26 Merrell Dow Pharmaceuticals Inc. Analogs of hirudin having antiplatelet activity
GB9023149D0 (en) * 1990-10-24 1990-12-05 British Bio Technology Proteins and nucleic acids
US5837808A (en) * 1991-08-20 1998-11-17 Baxter International Inc. Analogs of hirudin
WO1993004082A1 (en) * 1991-08-20 1993-03-04 Baxter International Inc. Analogs of hirudin
GB9209032D0 (en) * 1992-04-25 1992-06-10 Ciba Geigy Ag New peptide derivatives
NZ268159A (en) * 1993-06-11 1997-03-24 Merrell Pharma Inc Anticoagulant and antiplatelet peptides and their use
DE4404168A1 (de) * 1994-02-10 1995-08-17 Hoechst Ag Hirudinderivate und Verfahren zu deren Herstellung
US8377863B2 (en) * 2007-05-29 2013-02-19 Unigene Laboratories Inc. Peptide pharmaceutical for oral delivery
CA2973099C (en) 2015-01-12 2021-09-14 Enteris Biopharma, Inc. Solid oral dosage forms

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3586333T2 (de) * 1984-03-27 1992-12-10 Transgene Sa Expressionsvektoren fuer hirudin, transformierte zellen und verfahren zur herstellung von hirudin.
DE3429430A1 (de) * 1984-08-10 1986-02-20 Hoechst Ag, 6230 Frankfurt Gentechnologisches verfahren zur herstellung von hirudin und mittel zur durchfuehrung dieses verfahrens
FR2607517B2 (fr) 1986-12-01 1989-12-22 Transgene Sa Vecteurs d'expression de variants de l'hirudine dans les levures, procede et produit obtenu

Also Published As

Publication number Publication date
DE68904330T2 (de) 1993-05-19
PT89923B (pt) 1994-05-31
ES2036809T3 (es) 1993-06-01
EP0332523B1 (fr) 1993-01-13
GR3007254T3 (enExample) 1993-07-30
ATE84571T1 (de) 1993-01-15
EP0332523A1 (fr) 1989-09-13
US5087613A (en) 1992-02-11
CA1341429C (fr) 2003-05-27
PT89923A (pt) 1989-11-10
JPH029390A (ja) 1990-01-12
FR2628429A1 (fr) 1989-09-15
JP2961118B2 (ja) 1999-10-12
DE68904330D1 (de) 1993-02-25

Similar Documents

Publication Publication Date Title
DE3772721D1 (de) Profilstueck und herstellungsverfahren.
DE69022567D1 (de) Polycarbonat-polydimethylsiloxan copolymer und herstellungsverfahren.
DE3888910D1 (de) Fensterdichtungsprofil und Herstellungsverfahren.
DE3574789D1 (de) Prozessregler.
DE3778944D1 (de) Dreidimensionale integrierte schaltung und deren herstellungsverfahren.
DE3786900D1 (de) Optischer verbinder und dessen herstellungsverfahren.
IT8721835A0 (it) Differenziale perfezionato concavita' dei pignoni di pari profondita'.
IT8821618A0 (it) Tenuta di flusso senza contatto.
DE3883551D1 (de) Druckausbalancierte Dichtung mit "S" Querschnitt.
DE3582760D1 (de) Mikrostrukturherstellungsverfahren.
DE3574477D1 (de) Neue pfropfcopolymere und ihr herstellungsverfahren.
DE3574875D1 (de) Linsenzusammensetzung, gegenstand und herstellungsverfahren.
GR3007254T3 (enExample)
DE3577759D1 (de) Prozessregler.
BR8504241A (pt) Producao de dioxido de cloro
DE3483551D1 (de) Propylen-aethylen-copolymer mit hoher festigkeit und dessen herstellungsverfahren.
DE3481109D1 (de) Antihaemophilie-faktor-viii-konzentrat und dessen herstellungsverfahren.
DE3850487D1 (de) Kontaktfreies profilierungsverfahren.
FI894901A0 (fi) Menetelmä klooridioksidin valmistamiseksi
DE3865417D1 (de) Vinylester-latizes.
MA20407A1 (fr) Derives de l'hydroxy-4-2h-1-benzothiopyran-2-one,leurs preparations et applications
IT1226746B (it) Elemento costruttivo, nonche' metodo per la produzione dello stesso.
FI873477A7 (fi) Muovilla päällystetty vuota tai kangas ja menetelmä sen valmistamiseksi.
DE68904329D1 (de) Chlorerzeugungsverfahren.
IT8620970A0 (it) Eteri 5,6-epossi-7-ossabicicloeptano sostituiti utili nel trattamento di trombosi.

Legal Events

Date Code Title Description
ST Notification of lapse